You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 60 No. 12, December 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on ISI (15)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Genetic Counseling/ Testing/ Therapy
 •Amyotrophic Lateral Sclerosis
 •Neurogenetics
 •Neuromuscular diseases
 •Alert me on articles by topic

Mutation Screening of the ALS2 Gene in Sporadic and Familial Amyotrophic Lateral Sclerosis

Collette K. Hand, PhD; Rebecca S. Devon, PhD; Francois Gros-Louis, MSc; Daniel Rochefort, MSc; Jawad Khoris, MD; Vincent Meininger, MD; Jean-Pierre Bouchard, MD; William Camu, MD, PhD; Michael R. Hayden, MD, PhD; Guy A. Rouleau, MD, PhD

Arch Neurol. 2003;60:1768-1771.

Background  Mutations in the ALS2 gene cause juvenile-onset autosomal recessive amyotrophic lateral sclerosis (ALS) and hereditary spastic paraplegia.

Objective  To assess the role of ALS2 among more common forms of ALS.

Methods  DNA from 95 unrelated familial, 95 unrelated sporadic, and 11 early-onset ALS patients was screened for mutations in ALS2 by denaturing high-performance liquid chromatography and direct sequencing of polymerase chain reaction–amplified fragments. Each variant identified was also analyzed among control subjects. All 34 exons of ALS2 plus the 5' and 3' untranslated region were screened.

Results  We detected 23 novel sequence variants; however, none is disease-associated.

Conclusion  Mutations of ALS2 are not a common cause of ALS.


From the Centre for Research in Neuroscience, McGill University, and Montréal General Hospital Research Institute, Montréal (Drs Hand and Rouleau and Messrs Gros-Louis and Rochefort), and Department of Neurology, Hôpital de l'Enfant Jesus, Quebec City (Dr Bouchard), Quebec; and Centre for Molecular Medicine and Therapeutics, Department of Medical Genetics, University of British Columbia, and Children and Women's Hospital, Vancouver (Drs Devon and Hayden); and ALS Center of Montpellier, Department of Clinical Neurophysiology, University Hospitals of Montpellier, Montpellier (Drs Khoris and Camu), and Service de Neurologie, Division Mazarin, Hôpital Pitie Salpetriere, Paris (Dr Meininger); France. Drs Hand and Devon contributed equally to this article. Dr Hand is now affiliated with the Department of Pathology, University College Cork, Cork, Ireland.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

ADULT-ONSET PRIMARY LATERAL SCLEROSIS IS NOT ASSOCIATED WITH MUTATIONS IN THE ALS2 GENE
Brugman et al.
Neurology 2007;69:702-704.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.